Takeda gets ADZYNMA FDA approval for cTTP treatment: A new era in rare disease therapy

Takeda has achieved a monumental milestone in rare disease therapy with the U.S. Food and Drug Administration's approval of ADZYNMA (ADAMTS13, recombinant-krhn) for the treatment ... Read More